Building the future for Ipsen
Posted on August 22nd, 2018
John Turner Construction is delighted to have been appointed by Ipsen Biopharm Limited for the design and build of a new administrative building with a pharmaceutical packaging and dispatch facility in Wrexham.
Located within the overall Ipsen Biopharm site boundary on Wrexham Industrial Estate, the new three storey building, named Building One, will incorporate a double height ground floor packaging facility including a dispatch area, packing lines, cold stores and a reception. The first and second floors will incorporate administrative and office spaces with a goods lift.
The new Ipsen facility will be constructed over a 52 week programme period while the existing site remains fully operational. Building One will comprise a steel frame, in situ concrete floors, a steel feature staircase along with a roof terrace and balustrading. Externally, a blue ceramic rainscreen facade wraps around the building with aluminium curtain walling.
Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology, endocrinology, neuroscience and rare diseases developing processes and manufacturing products. Ipsen also contributes to research financing and operates worldwide.
One of three UK locations employing over 350 staff, the North Wales site has been in Wrexham since 1995 and is the Ipsen Group’s Biologics Development and Manufacturing campus which is the foundation of the company’s neurology franchise.
Providing research and manufacturing through to the distribution of medicines for neurological disorders, this centre of excellence in biologics is responsible for one of Ipsen’s key products, Dysport, which is a sterile injectable drug that treats several targeted debilitating diseases. It is dispensed all around the world in 115 different countries where it makes a meaningful difference to patient’s lives in therapeutic applications.